• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2020-2026

report cover
  • 22 June 2020
  • Pharmaceuticals
  • 95 Pages
  • Report Code: 24LS-8659
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Chric Myeloid Leukemia Treatment -MARKET ADVISORY SERVICES

This report focuses on the global Chronic Myeloid Leukemia (CML) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Myeloid Leukemia (CML) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.


The key players covered in this study

  • Novartis AG
  • Bristol-Myers Squibb
  • Teva Pharmaceuticals Industries Ltd.
  • ARIAD Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Hospira, Inc.
  • Prism Pharmaceuticals
  • Incyte Corporation
  • Bio-Path Holdings
  • Stragen Pharma SA
  • Otsuka Pharmaceutical Co., Ltd.


Market segment by Type, the product can be split into

  • Targeted Therapy
  • Chemotherapy
  • Radiation Therapy
  • Splenectomy
  • Stem Cell Transplant

Market segment by Application, split into

  • Hospitals
  • Clinic
  • Others


Market segment by Regions/Countries, this report covers

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America


The study objectives of this report are:

  • To analyze global Chronic Myeloid Leukemia (CML) Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Chronic Myeloid Leukemia (CML) Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.


In this study, the years considered to estimate the market size of Chronic Myeloid Leukemia (CML) Treatment are as follows:

  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Myeloid Leukemia (CML) Treatment Revenue
1.4 Market Analysis by Type
1.4.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Targeted Therapy
1.4.3 Chemotherapy
1.4.4 Radiation Therapy
1.4.5 Splenectomy
1.4.6 Stem Cell Transplant
1.5 Market by Application
1.5.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Chronic Myeloid Leukemia (CML) Treatment Industry Impact
1.6.1 How the Covid-19 is Affecting the Chronic Myeloid Leukemia (CML) Treatment Industry
1.6.1.1 Chronic Myeloid Leukemia (CML) Treatment Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Chronic Myeloid Leukemia (CML) Treatment Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Chronic Myeloid Leukemia (CML) Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Global Growth Trends by Regions
2.1 Chronic Myeloid Leukemia (CML) Treatment Market Perspective (2015-2026)
2.2 Chronic Myeloid Leukemia (CML) Treatment Growth Trends by Regions
2.2.1 Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Myeloid Leukemia (CML) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Myeloid Leukemia (CML) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Myeloid Leukemia (CML) Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Market Size
3.1.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Revenue (2015-2020)
3.1.2 Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio
3.2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2019
3.3 Chronic Myeloid Leukemia (CML) Treatment Key Players Head office and Area Served
3.4 Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
3.5 Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2021-2026)

5 Chronic Myeloid Leukemia (CML) Treatment Breakdown Data by Application (2015-2026)
5.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)
5.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
6.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in North America (2019-2020)
6.3 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
6.4 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
7.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Europe (2019-2020)
7.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
7.4 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

8 China
8.1 China Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
8.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in China (2019-2020)
8.3 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
8.4 China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
9.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Japan (2019-2020)
9.3 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
9.4 Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
10.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

11 India
11.1 India Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
11.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in India (2019-2020)
11.3 India Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
11.4 India Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size (2015-2020)
12.2 Chronic Myeloid Leukemia (CML) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis AG
13.1.1 Novartis AG Company Details
13.1.2 Novartis AG Business Overview and Its Total Revenue
13.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Introduction
13.1.4 Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020))
13.1.5 Novartis AG Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Introduction
13.2.4 Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Teva Pharmaceuticals Industries Ltd.
13.3.1 Teva Pharmaceuticals Industries Ltd. Company Details
13.3.2 Teva Pharmaceuticals Industries Ltd. Business Overview and Its Total Revenue
13.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.3.4 Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.3.5 Teva Pharmaceuticals Industries Ltd. Recent Development
13.4 ARIAD Pharmaceuticals, Inc.
13.4.1 ARIAD Pharmaceuticals, Inc. Company Details
13.4.2 ARIAD Pharmaceuticals, Inc. Business Overview and Its Total Revenue
13.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.4.4 ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.4.5 ARIAD Pharmaceuticals, Inc. Recent Development
13.5 Pfizer, Inc.
13.5.1 Pfizer, Inc. Company Details
13.5.2 Pfizer, Inc. Business Overview and Its Total Revenue
13.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.5.4 Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.5.5 Pfizer, Inc. Recent Development
13.6 Hospira, Inc.
13.6.1 Hospira, Inc. Company Details
13.6.2 Hospira, Inc. Business Overview and Its Total Revenue
13.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
13.6.4 Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.6.5 Hospira, Inc. Recent Development
13.7 Prism Pharmaceuticals
13.7.1 Prism Pharmaceuticals Company Details
13.7.2 Prism Pharmaceuticals Business Overview and Its Total Revenue
13.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Introduction
13.7.4 Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.7.5 Prism Pharmaceuticals Recent Development
13.8 Incyte Corporation
13.8.1 Incyte Corporation Company Details
13.8.2 Incyte Corporation Business Overview and Its Total Revenue
13.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Introduction
13.8.4 Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.8.5 Incyte Corporation Recent Development
13.9 Bio-Path Holdings
13.9.1 Bio-Path Holdings Company Details
13.9.2 Bio-Path Holdings Business Overview and Its Total Revenue
13.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Introduction
13.9.4 Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.9.5 Bio-Path Holdings Recent Development
13.10 Stragen Pharma SA
13.10.1 Stragen Pharma SA Company Details
13.10.2 Stragen Pharma SA Business Overview and Its Total Revenue
13.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Introduction
13.10.4 Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
13.10.5 Stragen Pharma SA Recent Development
13.11 Otsuka Pharmaceutical Co., Ltd.
10.11.1 Otsuka Pharmaceutical Co., Ltd. Company Details
10.11.2 Otsuka Pharmaceutical Co., Ltd. Business Overview and Its Total Revenue
10.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
10.11.4 Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)
10.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables

Table 1. Chronic Myeloid Leukemia (CML) Treatment Key Market Segments

Table 2. Key Players Covered: Ranking by Chronic Myeloid Leukemia (CML) Treatment Revenue

Table 3. Ranking of Global Top Chronic Myeloid Leukemia (CML) Treatment Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Targeted Therapy

Table 6. Key Players of Chemotherapy

Table 7. Key Players of Radiation Therapy

Table 8. Key Players of Splenectomy

Table 9. Key Players of Stem Cell Transplant

Table 10. COVID-19 Impact Global Market: (Four Chronic Myeloid Leukemia (CML) Treatment Market Size Forecast Scenarios)

Table 11. Opportunities and Trends for Chronic Myeloid Leukemia (CML) Treatment Players in the COVID-19 Landscape

Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 13. Key Regions/Countries Measures against Covid-19 Impact

Table 14. Proposal for Chronic Myeloid Leukemia (CML) Treatment Players to Combat Covid-19 Impact

Table 15. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 16. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions (US$ Million): 2020 VS 2026

Table 17. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions (2015-2020) (US$ Million)

Table 18. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2015-2020)

Table 19. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 20. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2021-2026)

Table 21. Market Top Trends

Table 22. Key Drivers: Impact Analysis

Table 23. Key Challenges

Table 24. Chronic Myeloid Leukemia (CML) Treatment Market Growth Strategy

Table 25. Main Points Interviewed from Key Chronic Myeloid Leukemia (CML) Treatment Players

Table 26. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Players (2015-2020) (Million US$)

Table 27. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Players (2015-2020)

Table 28. Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2019)

Table 29. Global Chronic Myeloid Leukemia (CML) Treatment by Players Market Concentration Ratio (CR5 and HHI)

Table 30. Key Players Headquarters and Area Served

Table 31. Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service

Table 32. Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 35. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Type (2015-2020)

Table 36. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2021-2026)

Table 37. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Application (2015-2020)

Table 38. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 39. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Application (2021-2026)

Table 40. North America Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 41. North America Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 42. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 43. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 44. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 45. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 46. Europe Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 47. Europe Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 48. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 49. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 50. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 51. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 52. China Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 53. China Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 54. China Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 55. China Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 56. China Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 57. China Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 58. Japan Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 59. Japan Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 60. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 61. Japan Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 62. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 63. Japan Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 64. Southeast Asia Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 65. Southeast Asia Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 66. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 67. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 68. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 69. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 70. India Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 71. India Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 72. India Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 73. India Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 74. India Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 75. India Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 76. Central & South America Key Players Chronic Myeloid Leukemia (CML) Treatment Revenue (2019-2020) (Million US$)

Table 77. Central & South America Key Players Chronic Myeloid Leukemia (CML) Treatment Market Share (2019-2020)

Table 78. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2015-2020) (Million US$)

Table 79. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2015-2020)

Table 80. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2015-2020) (Million US$)

Table 81. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2015-2020)

Table 82. Novartis AG Company Details

Table 83. Novartis AG Business Overview

Table 84. Novartis AG Product

Table 85. Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 86. Novartis AG Recent Development

Table 87. Bristol-Myers Squibb Company Details

Table 88. Bristol-Myers Squibb Business Overview

Table 89. Bristol-Myers Squibb Product

Table 90. Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 91. Bristol-Myers Squibb Recent Development

Table 92. Teva Pharmaceuticals Industries Ltd. Company Details

Table 93. Teva Pharmaceuticals Industries Ltd. Business Overview

Table 94. Teva Pharmaceuticals Industries Ltd. Product

Table 95. Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 96. Teva Pharmaceuticals Industries Ltd. Recent Development

Table 97. ARIAD Pharmaceuticals, Inc. Company Details

Table 98. ARIAD Pharmaceuticals, Inc. Business Overview

Table 99. ARIAD Pharmaceuticals, Inc. Product

Table 100. ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 101. ARIAD Pharmaceuticals, Inc. Recent Development

Table 102. Pfizer, Inc. Company Details

Table 103. Pfizer, Inc. Business Overview

Table 104. Pfizer, Inc. Product

Table 105. Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 106. Pfizer, Inc. Recent Development

Table 107. Hospira, Inc. Company Details

Table 108. Hospira, Inc. Business Overview

Table 109. Hospira, Inc. Product

Table 110. Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 111. Hospira, Inc. Recent Development

Table 112. Prism Pharmaceuticals Company Details

Table 113. Prism Pharmaceuticals Business Overview

Table 114. Prism Pharmaceuticals Product

Table 115. Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 116. Prism Pharmaceuticals Recent Development

Table 117. Incyte Corporation Business Overview

Table 118. Incyte Corporation Product

Table 119. Incyte Corporation Company Details

Table 120. Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 121. Incyte Corporation Recent Development

Table 122. Bio-Path Holdings Company Details

Table 123. Bio-Path Holdings Business Overview

Table 124. Bio-Path Holdings Product

Table 125. Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 126. Bio-Path Holdings Recent Development

Table 127. Stragen Pharma SA Company Details

Table 128. Stragen Pharma SA Business Overview

Table 129. Stragen Pharma SA Product

Table 130. Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 131. Stragen Pharma SA Recent Development

Table 132. Otsuka Pharmaceutical Co., Ltd. Company Details

Table 133. Otsuka Pharmaceutical Co., Ltd. Business Overview

Table 134. Otsuka Pharmaceutical Co., Ltd. Product

Table 135. Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020) (Million US$)

Table 136. Otsuka Pharmaceutical Co., Ltd. Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Type: 2020 VS 2026

Figure 2. Targeted Therapy Features

Figure 3. Chemotherapy Features

Figure 4. Radiation Therapy Features

Figure 5. Splenectomy Features

Figure 6. Stem Cell Transplant Features

Figure 7. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2020 VS 2026

Figure 8. Hospitals Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Chronic Myeloid Leukemia (CML) Treatment Report Years Considered

Figure 12. Global Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth 2015-2026 (US$ Million)

Figure 13. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions: 2020 VS 2026

Figure 14. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2021-2026)

Figure 15. Porter's Five Forces Analysis

Figure 16. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Players in 2019

Figure 17. Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2019

Figure 18. The Top 10 and 5 Players Market Share by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2019

Figure 19. North America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. China Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. India Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Central & South America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018

Figure 27. Novartis AG Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 28. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018

Figure 29. Bristol-Myers Squibb Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 30. Teva Pharmaceuticals Industries Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 31. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 32. ARIAD Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 33. ARIAD Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 34. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 35. Pfizer, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 36. Hospira, Inc. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 37. Hospira, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 38. Prism Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 39. Prism Pharmaceuticals Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 40. Incyte Corporation Total Revenue (US$ Million): 2019 Compared with 2018

Figure 41. Incyte Corporation Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 42. Bio-Path Holdings Total Revenue (US$ Million): 2019 Compared with 2018

Figure 43. Bio-Path Holdings Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 44. Stragen Pharma SA Total Revenue (US$ Million): 2019 Compared with 2018

Figure 45. Stragen Pharma SA Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 46. Otsuka Pharmaceutical Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018

Figure 47. Otsuka Pharmaceutical Co., Ltd. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2015-2020)

Figure 48. Bottom-up and Top-down Approaches for This Report

Figure 49. Data Triangulation

Figure 50. Key Executives Interviewed

Novartis AG

Bristol-Myers Squibb

Teva Pharmaceuticals Industries Ltd.

ARIAD Pharmaceuticals, Inc.

Pfizer, Inc.

Hospira, Inc.

Prism Pharmaceuticals

Incyte Corporation

Bio-Path Holdings

Stragen Pharma SA

Otsuka Pharmaceutical Co., Ltd.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3042

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase